High B7‐H3 expression is linked to increased risk of prostate cancer progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High B7‐H3 expression is linked to increased risk of prostate cancer progression
Authors
Keywords
-
Journal
PATHOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-11
DOI
10.1111/pin.12999
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma
- (2018) Rui Cheng et al. APMIS
- B7-H3 in tumors: friend or foe for tumor immunity?
- (2018) Gen Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genetic and clinical characterization of B7-H3(CD276) expression and epigenetic regulation in diffuse brain glioma
- (2018) Zhiliang Wang et al. CANCER SCIENCE
- Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer
- (2018) Waldemar Wilczak et al. EUROPEAN UROLOGY
- 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer
- (2018) Martina Kluth et al. GENES CHROMOSOMES & CANCER
- B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
- (2018) Peixin Dong et al. Frontiers in Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The prognostic value of immune checkpoints in oral squamous cell carcinoma
- (2018) Meri Sieviläinen et al. ORAL DISEASES
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis
- (2017) Yi Li et al. ONCOLOGY REPORTS
- B7-H3 is related to tumor progression in ovarian cancer
- (2017) Jingjing Zhang et al. ONCOLOGY REPORTS
- Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer
- (2017) Martina Kluth et al. Oncotarget
- International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading
- (2016) Lars Egevad et al. APMIS
- B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis
- (2016) Zhimeng Ye et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
- (2016) E. Picarda et al. CLINICAL CANCER RESEARCH
- Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
- (2016) Guido Sauter et al. EUROPEAN UROLOGY
- Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
- (2016) B Benzon et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Deletion of 18q is a strong and independent prognostic feature in prostate cancer
- (2016) Martina Kluth et al. Oncotarget
- Deletion of 8p is an independent prognostic parameter in prostate cancer
- (2016) Martina Kluth et al. Oncotarget
- Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer
- (2016) Shanshan Wu et al. Oncotarget
- The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
- (2015) Christoph Burdelski et al. BMC CANCER
- ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer
- (2015) Pei Zhang et al. FEBS LETTERS
- Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer
- (2015) Martina Kluth et al. INTERNATIONAL JOURNAL OF CANCER
- B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer
- (2015) FEN LIU et al. Molecular Medicine Reports
- Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
- (2015) Christoph Burdelski et al. PLoS One
- Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
- (2015) Martina Kluth et al. Oncotarget
- Clinical significance of different types ofp53gene alteration in surgically treated prostate cancer
- (2014) Martina Kluth et al. INTERNATIONAL JOURNAL OF CANCER
- PTEN function: the long and the short of it
- (2014) Benjamin D. Hopkins et al. TRENDS IN BIOCHEMICAL SCIENCES
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers
- (2013) Laura Stumm et al. JOURNAL OF CLINICAL PATHOLOGY
- B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma
- (2013) Jinhua Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers
- (2013) Antje Krohn et al. JOURNAL OF PATHOLOGY
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- High mitochondria content is associated with prostate cancer disease progression
- (2013) Katharina Grupp et al. Molecular Cancer
- B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis
- (2013) Ling Wang et al. PLoS One
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Standardization of Gleason grading among 337 European pathologists
- (2012) Lars Egevad et al. HISTOPATHOLOGY
- Interobserver reproducibility of Gleason grading of prostatic adenocarcinoma among general pathologists
- (2012) RV Singh et al. INDIAN JOURNAL OF CANCER
- Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression inERG-fusion-positive cancers
- (2012) Julia Müller et al. INTERNATIONAL JOURNAL OF CANCER
- B7-H3 overexpression in pancreatic cancer promotes tumor progression
- (2012) XIN ZHAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
- (2012) Yishan Liu et al. INTERNATIONAL JOURNAL OF UROLOGY
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
- (2011) Jan C Brase et al. BMC CANCER
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
- (2011) Andreas Brunner et al. GYNECOLOGIC ONCOLOGY
- B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
- (2011) Hexing Yuan et al. JOURNAL OF UROLOGY
- Current Perspectives on Gleason Grading of Prostate Cancer
- (2011) Kenneth A. Iczkowski et al. Current Urology Reports
- B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis
- (2010) Takaaki Arigami et al. ANNALS OF SURGERY
- B7-H3 and Its Role in Antitumor Immunity
- (2010) Martin Loos et al. Clinical & Developmental Immunology
- Evaluation of B7-H3 Expression as a Biomarker of Biochemical Recurrence After Salvage Radiation Therapy for Recurrent Prostate Cancer
- (2010) Alexander S. Parker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer
- (2009) Martin Loos et al. BMC CANCER
- The contrasting role of B7-H3
- (2008) K. A. Hofmeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now